Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases

The Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases opportunity is a forecasted federal cooperative agreement issued by the Centers for Disease Control and Prevention through the National Center for Emerging and Zoonotic Infectious Diseases under opportunity number CDC-RFA-CK-26-0107. The opportunity is listed on Grants.gov as part of Assistance Listing 93.084, Prevention of Disease, Disability, and Death by Infectious Diseases. The program is intended to establish a unified national funding mechanism that strengthens the ability of healthcare systems, clinicians, public health organizations, and other healthcare stakeholders to prevent, detect, and respond to infectious disease threats across the United States. The opportunity reflects CDC priorities related to national infectious disease preparedness, healthcare-associated infection prevention, antimicrobial resistance response, emergency coordination, and public health infrastructure development. The cooperative agreement is designed to support organizations that are directly involved in patient care, infection prevention, public health coordination, and infectious disease control activities. The funding announcement emphasizes strengthening frontline engagement and improving national readiness for both emerging and reemerging infectious disease threats. Supported activities may include workforce development, healthcare training programs, infection prevention education, communication strategies, preparedness planning, emergency staffing coordination, antimicrobial resistance response initiatives, and public health coordination systems. The program specifically references the need to expand national infection prevention capacity and improve coordination among healthcare and public health partners during emergency response efforts. Funding under this opportunity is substantial, with an estimated total program funding amount of 150,000,000 dollars. The estimated award ceiling is 30,000,000 dollars and the award floor is 1,000,000 dollars. CDC anticipates making approximately 15 awards under the cooperative agreement structure. No cost sharing or matching requirement is identified in the forecast notice. The anticipated project start date is September 30, 2026, and the estimated award date is August 31, 2026. The forecast notice does not specify a period of performance length, indirect cost limitations, or subaward restrictions in the currently available materials. Because this is a cooperative agreement, CDC is expected to maintain substantial programmatic involvement with funded recipients during implementation. Eligibility for this opportunity is broad and includes numerous categories of governmental, nonprofit, educational, tribal, and commercial entities. Eligible applicants include state governments, county governments, city or township governments, special district governments, public housing authorities, Native American tribal governments, Native American tribal organizations, public and private institutions of higher education, independent school districts, nonprofit organizations with and without 501(c)(3) status, for-profit organizations other than small businesses, and small businesses. The notice also identifies unrestricted eligibility subject to any additional clarifications that may appear in the final announcement. Because the opportunity focuses on national infectious disease prevention infrastructure, the funding scope appears intended to support organizations capable of operating at scale within healthcare, clinical, or public health environments. The estimated application due date is June 13, 2026, and electronically submitted applications must be received no later than 11:59 PM Eastern Time on the deadline date. The estimated posting date for the full application announcement is April 14, 2026, while the forecasted opportunity notice itself was updated on May 5, 2026. The archive date listed is July 13, 2026. The funding notice does not identify any mandatory or optional pre-application requirements such as letters of intent, concept papers, or pre-proposals. Likewise, no webinar requirements, technical assistance sessions, or question-and-answer deadlines are currently provided in the forecast materials. Applicants will likely be required to submit applications electronically through Grants.gov once the final package becomes available. The opportunity description emphasizes the importance of strengthening healthcare and public health coordination during emergency response situations. CDC indicates that the funding will help support surge staffing capabilities, communication infrastructure, training systems, and operational preparedness needed to respond effectively to infectious disease emergencies. The initiative is intended to improve implementation of timely public health responses and generate expert insights that can strengthen national public health guidance and practice. The focus on antimicrobial resistance and infection control further aligns the program with broader federal priorities related to healthcare-associated infections and healthcare system resilience. The primary agency contact for this opportunity is Trisia Shannon at the Centers for Disease Control and Prevention. The listed contact phone number is 404-639-0063 and the contact email is xki5@cdc.gov. Because the opportunity is currently forecasted, detailed application instructions, required forms, evaluation criteria, and scoring methodologies are not yet publicly available in the source material. Additional operational details are expected to become available when the full notice of funding opportunity is officially posted.

Emphasize national infectious disease prevention capacity healthcare coordination antimicrobial resistance preparedness workforce development and emergency response infrastructure in the application narrative.